Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

The death receptors TRAIL-R1 and TRAIL-R2 are frequently overexpressed in cancer and there is an emerging evidence for their important role in malignant progression, also in the case of pancreatic ductal adenocarcinoma (PDAC).oma (PDAC).